Scientific News Earnings Preview What To Expect From Boston Scientific S Report
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Earnings Preview What To Expect From Boston Scientific S Report is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
What to Expect from Boston Scientific's Earnings
Analysts are estimating that Boston Scientific will report an earnings per share (EPS) of $0.71. Boston Scientific bulls will hope to hear the company announce they've not only beaten that estimate, ... Read More
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect. Boston Scientific beat analysts’ revenue expectations by 3.4% ... Read More
Boston Scientific (BSX) Stock Is Up, What You Need To Know
What Happened? Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's ... Read More
Boston Scientific continues to win in electrophysiology
Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players. Read More
Boston Scientific: Q3 Earnings Snapshot

For the current quarter ending in December, Boston Scientific expects its per-share earnings to range from 77 cents to 79 cents. The company expects full-year earnings in the range of $3.02 to $3.04 ... Read More
These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Morgan Stanley analyst Patrick Wood maintained Boston Scientific with an Overweight rating and raised the price target from $125 to $130. Wells Fargo analyst Larry Biegelsen maintained the stock with ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

